161 related articles for article (PubMed ID: 37239411)
21. Long non-coding RNA TP73-AS1 is a potential immune related prognostic biomarker for glioma.
Zhang B; Li Q; Wu B; Zhang S; Li L; Jin K; Li S; Li K; Wang Z; Lu Y; Xia L; Sun C
Aging (Albany NY); 2021 Feb; 13(4):5638-5649. PubMed ID: 33589576
[TBL] [Abstract][Full Text] [Related]
22. LncRNA SAMD12-AS1 down-regulates P53 to promote malignant progression of glioma.
Yu BX; Zou L; Li S; Du YL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8456-8467. PubMed ID: 31646576
[TBL] [Abstract][Full Text] [Related]
23. LncRNA TSLC1-AS1 is a novel tumor suppressor in glioma.
Qin X; Yao J; Geng P; Fu X; Xue J; Zhang Z
Int J Clin Exp Pathol; 2014; 7(6):3065-72. PubMed ID: 25031725
[TBL] [Abstract][Full Text] [Related]
24. LncRNA IDH1-AS1 suppresses cell proliferation and tumor growth in glioma.
Wang J; Quan Y; Lv J; Dong Q; Gong S
Biochem Cell Biol; 2020 Oct; 98(5):556-564. PubMed ID: 32990028
[TBL] [Abstract][Full Text] [Related]
25. A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma.
Lv QL; Hu L; Chen SH; Sun B; Fu ML; Qin CZ; Qu Q; Wang GH; He CJ; Zhou HH
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589728
[TBL] [Abstract][Full Text] [Related]
26. Long Noncoding RNA ASB16-AS1 Promotes Proliferation, Migration, and Invasion in Glioma Cells.
Zhang D; Zhou H; Liu J; Mao J
Biomed Res Int; 2019; 2019():5437531. PubMed ID: 30949502
[TBL] [Abstract][Full Text] [Related]
27. Silencing of lncRNA LBX2-AS1 suppresses glioma cell proliferation and metastasis through the Akt/GSK3β pathway in vitro.
Wen H; Li Z; Song S; Xu L; Tong X; Yan H
Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(4):446-453. PubMed ID: 33637977
[TBL] [Abstract][Full Text] [Related]
28. The transcription factor USF1 promotes glioma cell invasion and migration by activating lncRNA HAS2-AS1.
Wang J; Gu J; You A; Li J; Zhang Y; Rao G; Ge X; Zhang K; Li J; Liu X; Wang Q; Lin T; Cheng L; Zhu M; Wu X; Wang D
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32776110
[TBL] [Abstract][Full Text] [Related]
29. Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma.
Tao C; Luo H; Chen L; Li J; Zhu X; Huang K
Bioengineered; 2021 Dec; 12(1):4016-4031. PubMed ID: 34288803
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA FOXD2-AS1 promotes glioma malignancy and tumorigenesis via targeting miR-185-5p/CCND2 axis.
Shen F; Chang H; Gao G; Zhang B; Li X; Jin B
J Cell Biochem; 2019 Jun; 120(6):9324-9336. PubMed ID: 30520141
[TBL] [Abstract][Full Text] [Related]
31. Expression analysis of PPAR-related lncRNAs in breast cancer.
Ghafouri-Fard S; Nicknam A; Safarzadeh A; Eslami S; Samsami M; Jamali E
Pathol Res Pract; 2023 Nov; 251():154844. PubMed ID: 37820438
[TBL] [Abstract][Full Text] [Related]
32. An autophagy-related long non-coding RNA signature for glioma.
Luan F; Chen W; Chen M; Yan J; Chen H; Yu H; Liu T; Mo L
FEBS Open Bio; 2019 Apr; 9(4):653-667. PubMed ID: 30984540
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA ZEB1-AS1 promotes glioma cell proliferation, migration and invasion through regulating miR-577.
Wei N; Wei H; Zhang H
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3085-3093. PubMed ID: 29863254
[TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNA FAM83H-AS1 exerts an oncogenic role in glioma through epigenetically silencing CDKN1A (p21).
Bi YY; Shen G; Quan Y; Jiang W; Xu F
J Cell Physiol; 2018 Nov; 233(11):8896-8907. PubMed ID: 29870057
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of FOXD2-AS1 enhances proliferation and impairs differentiation of glioma stem cells by activating the NOTCH pathway via TAF-1.
Wang Y; Cheng Y; Yang Q; Kuang L; Liu G
J Cell Mol Med; 2022 May; 26(9):2620-2632. PubMed ID: 35419917
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA AGAP2-AS1 promotes the proliferation of glioma cells by sponging miR-15a/b-5p to upregulate the expression of HDGF and activating Wnt/β-catenin signaling pathway.
Zheng Y; Lu S; Xu Y; Zheng J
Int J Biol Macromol; 2019 May; 128():521-530. PubMed ID: 30684575
[TBL] [Abstract][Full Text] [Related]
37. Gliomas with Downregulation of lncRNA SLC25A21-AS1 Carry a Dismal Prognosis and an Accelerated Progression in Cell Proliferation, Migration and Invasion.
Zhu M; Li K; Zhang J
Mol Biotechnol; 2022 Aug; 64(8):936-944. PubMed ID: 35266110
[TBL] [Abstract][Full Text] [Related]
38. LncRNA FOXD1-AS1 acts as a potential oncogenic biomarker in glioma.
Gao YF; Liu JY; Mao XY; He ZW; Zhu T; Wang ZB; Li X; Yin JY; Zhang W; Zhou HH; Liu ZQ
CNS Neurosci Ther; 2020 Jan; 26(1):66-75. PubMed ID: 31102349
[TBL] [Abstract][Full Text] [Related]
39. LncRNA PCED1B-AS1 activates the proliferation and restricts the apoptosis of glioma through cooperating with miR-194-5p/PCED1B axis.
Yang J; Yu D; Liu X; Changyong E; Yu S
J Cell Biochem; 2020 Feb; 121(2):1823-1833. PubMed ID: 31680313
[TBL] [Abstract][Full Text] [Related]
40. LncRNA NNT-AS1 promote glioma cell proliferation and metastases through miR-494-3p/PRMT1 axis.
Zheng D; Chen D; Lin F; Wang X; Lu L; Luo S; Chen J; Xu X
Cell Cycle; 2020 Jul; 19(13):1621-1631. PubMed ID: 32420808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]